Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



snyderman nancy lynn MD Create: Alert

All | News | Filings
Date FiledTypeDescription
07/10/2023 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.
Txns: Paid exercise price by delivering 1,430 shares @ $29.88, valued at $42.7k
Exercised 5,957 options to buy @ $0
07/05/2023 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 20,000 options @ $4.11, valued at $82.2k
06/30/2023 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 12,732 options to buy @ $31.33, valued at $398.9k
Granted 5,985 options to buy @ $0
06/28/2023 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics, Inc.
Txns: Granted 3,000 shares @ $0
08/22/2022 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics, Inc.
Txns: Granted 2,100 shares @ $0
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2021 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics, Inc.
Txns: Granted 2,261 shares @ $0
10/26/2021 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Future Health ESG Corp.
Txns: Disposed/sold 1,688 shares @ $0
Disposed/sold 1,689 shares @ $0
09/16/2021 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Future Health ESG Corp.
Txns: Bought 27,351 warrants @ $1, valued at $27.4k
09/09/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/28/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/17/2020 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Bought 1,025 shares @ $9.72, valued at $10k
12/04/2020 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 11,509 options to buy @ $18.82, valued at $216.6k
Granted 5,578 options to buy @ $0
10/29/2020 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Granted 14,500 options @ $11.76, valued at $170.5k
10/29/2020 3 snyderman nancy lynn MD (Director) has filed a Form 3 on Lyra Therapeutics, Inc.
08/26/2020 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.
Txns: Granted 3,500 shares @ $0
05/22/2020 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 12,823 options to buy @ $16.85, valued at $216.1k
Granted 6,104 options to buy @ $0
08/26/2019 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.
Txns: Granted 2,083 shares @ $0
Granted 4,167 options to buy @ $34.1, valued at $142.1k
07/01/2019 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.
Txns: Bought 2,000 shares @ $37.12, valued at $74.2k
05/23/2019 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 22,400 options to buy @ $25.04, valued at $560.9k
04/09/2019 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.
Txns: Granted 5,000 shares @ $0
Granted 10,000 options to buy @ $21.04, valued at $210.4k
04/09/2019 3 snyderman nancy lynn MD (Director) has filed a Form 3 on Axonics Modulation Technologies, Inc.
05/24/2018 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 17,500 options to buy @ $45.64, valued at $798.7k
05/25/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
09/15/2016 4 snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 27,400 options to buy @ $47.65, valued at $1.3M
Granted 16,200 options to buy @ $47.65, valued at $771.9k
05/26/2016 3 snyderman nancy lynn MD (Director) has filed a Form 3 on Alkermes plc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy